SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-008497
Filing Date
2023-03-17
Accepted
2023-03-17 16:32:06
Documents
13
Period of Report
2023-03-16
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cdxc-20230316.htm   iXBRL 8-K 27097
2 EX-3.1 amendedandrestatedbylawsof.htm EX-3.1 151466
  Complete submission text file 0001628280-23-008497.txt   344170

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdxc-20230316.xsd EX-101.SCH 1893
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdxc-20230316_lab.xml EX-101.LAB 24893
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdxc-20230316_pre.xml EX-101.PRE 13052
7 EXTRACTED XBRL INSTANCE DOCUMENT cdxc-20230316_htm.xml XML 4610
Mailing Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024
Business Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024 310-388-6706
ChromaDex Corp. (Filer) CIK: 0001386570 (see all company filings)

IRS No.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37752 | Film No.: 23743099
SIC: 2833 Medicinal Chemicals & Botanical Products